Daily non-political popular news in brief.

Involving parents in therapy doubles success rates for bulimia treatment

In the first randomized controlled trial for adolescent bulimia nervosa to be completed in the US, researchers show that mobilizing parents to help an adolescent overcome the disorder can double the percentage of teens who were able to abstain from binge eating and purging after six months.

Read more »

Keywords: involving, parents, therapy, doubles, success, rates, bulimia, treatment, parent, double, rate

« Previous | Next »

Similar news on "Involving parents in therapy doubles success rates for bulimia treatment":

1. Risk of stroke doubles if diagnosed with Type 2 diabetes
   06-14-2007 · EurekAlert!
   Individuals diagnosed with Type 2 diabetes are at double the risk of having a stroke compared to those without diabetes, according to new research from the University of Alberta. It was found that the risk of a stroke is considered high within the first five years of treatment for Type 2 diabetes, and more than doubles the rate of occurrence.
   Similar news · Read more »
   
2. Dasatinib shows high early response rate as first treatment for chronic myelogenous leukemia
   06-02-2007 · EurekAlert!
   An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a phase II clinical trial at the University of Texas M. D. Anderson Cancer Center.
   Similar news · Read more »
   
3. International HIV/AIDS trial finds risks increase on episodic antiretroviral therapy
   11-29-2006 · EurekAlert!
   Results from one of the largest HIV/AIDS treatment trials ever conducted show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. In the study, the investigators used two predetermined levels of CD4+ T cells, the primary immune cell targeted by HIV, to guide them in respectively suspending or restarting the study participants on antiretroviral therapy.
   Similar news · Read more »
   
4. Decrease in breast cancer rates related to reduction in use of hormone replacement therapy
   04-18-2007 · EurekAlert!
   The sharp decline in the rate of new breast cancer cases in 2003 may be related to a national decline in the use of hormone replacement therapy (HRT). Age-adjusted breast cancer incidence rates in women in the United States fell 6.7 percent from 2002 to 2003. Prescriptions for HRT also declined rapidly in 2002 and 2003.
   Similar news · Read more »
   
5. Study shows interruption of antiretroviral therapy increases risk of disease and death
   11-30-2006 · EurekAlert!
   Findings from one of the largest HIV/AIDS therapy studies show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. Researchers affiliated with the Mailman School of Public Health led a large multi-center international study, known as Strategies for Management of Anti-Retroviral Therapies, or SMART, comparing two treatment strategies for people with human immunodeficiency virus. Findings demonstrate the value of continuous antiretroviral therapy.
   Similar news · Read more »
   
6. Treatment outcomes of patients with HIV and tuberculosis
   06-01-2007 · EurekAlert!
   In a retrospective study of 700 patients with culture-positive tuberculosis, relapse rates were found to be significantly higher in HIV-infected patients compared to HIV-uninfected patients following a rifamycin-based regimen. Furthermore, TB relapse rates were higher in HIV-infected patients who received intermittent or standard 6-month therapy when compared to those receiving daily or longer treatment.
   Similar news · Read more »
   
7. In largest U.S. Hep C trial, researchers determine weight-based dosing is key to optimal treatment
   12-27-2007 · EurekAlert!
   As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus showed treatment with weight-based REBETOL® (ribavirin, USP) in combination with pegylated interferon alfa-2b achieved significantly higher rates of sustained virologic response and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day.
   Similar news · Read more »
   
8. Multidisciplinary approach to treatment of heart attacks a success
   06-18-2007 · EurekAlert!
   Acute heart attacks can be successfully treated through a multidisciplinary team approach involving emergency medical services, emergency physicians, cardiologists and specialty centres, according to a study conducted by Dr. Jacobus S. de Villiers and colleagues in Calgary.
   Similar news · Read more »
   
9. Columbia research explores impact of gum disease therapy on pregnancy
   11-01-2006 · EurekAlert!
   A study published in the New England Journal of Medicine shows that treatment for periodontal disease in pregnant women does not result in a lower rate of adverse pregnancy outcomes such as preterm birth and low birth weight. At the same time, the study showed that periodontal treatment during pregnancy is safe. The researchers recommend additional studies to assess the potential benefits of the treatment.
   Similar news · Read more »
   
10. Increased hemodialysis may lead to greater survival rates
    11-06-2006 · EurekAlert!
    A study recently published in Hemodialysis International found that more frequent hemodialysis treatments (five or more weekly) can significantly increase the survival rate of patients suffering from irreversible kidney failure. Typical treatment in the US generally involves three sessions weekly.
    Similar news · Read more »